Table 3.

Result of analysis of forward stepwise ordered logit regression models in SLE patients

Variables	B	SE	P	Exp (B)	95% CI
					Lower	Higher
Step 1
MFI total score	0.05	0.02	0.005**	1.05	1.01	1.09
Step 2
DMARDs usage	− 2.36	1.05	0.025*	0.10	0.01	0.75
MFI total score	0.05	0.02	0.005**	1.05	1.01	1.09
Step 3
DMARDs usage	− 2.58	1.06	0.015*	0.08	0.01	0.61
MFI total score	0.04	0.02	0.026*	1.04	1.01	1.08
Disease duration	0.12	0.06	0.035*	1.13	1.01	1.26
Step 4
Having child	− 1.45	0.63	0.031*	0.19	0.06	0.97
DMARDs usage	− 2.88	1.11	0.009**	0.13	0.01	0.87
MFI total score	0.05	0.02	0.005**	1.07	1.00	1.12
Disease duration	0.13	0.06	0.039*	1.14	1.02	1.30
Step 5
Age	0.11	0.04	0.002**	1.11	1.04	1.19
Having child	− 1.57	0.70	0.024*	0.21	0.05	0.81
DMARDs usage	− 3.28	1.16	0.004**	0.04	0.01	0.36
MFI total score	0.06	0.02	0.006**	1.06	1.02	1.10
Disease duration	0.15	0.07	0.043*	1.16	1.00	1.34

SLE Systemic Lupus Erythematosus, DMARDs Disease-Modifying Anti-rheumatic Drugs, MFI Multiple Fatigue Inventory, OR odds ratio, CI confidence interval

*P < 0.05; **P < 0.01